Fumou Sun

6PUBLICATIONS
24CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsEconomic models and forecastingHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.

Fumou Sun, Yan Cheng, Catherine Ma

|Nov 06, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Yan Cheng, Fumou Sun, Daisy V Alapat

|Mar 05, 2024
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng

|Feb 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.

Wancheng Guo, Yihao Zhan, David Mery

|Jul 06, 2022
FOXM1 regulates glycolysis and energy production in multiple myeloma.

Yan Cheng, Fumou Sun, Krista Thornton

|Jan 28, 2022
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.

Yijiang Shi, Fumou Sun, Yan Cheng

Pageof 1

Frequent Collaborators

6 joint publications

Yan Cheng

4 joint publications

Fenghuang Zhan

3 joint publications

Siegfried Janz

3 joint publications

Carolina Schinke